StocksMedium•5 November 2026•
1 min read
Cabaletta Bio Reports Narrower-Than-Expected Q3 2026 Loss
Key Facts
1Cabaletta Bio reported a GAAP EPS loss of $0.28, beating analyst estimates by $0.03.
Cabaletta Bio reported a GAAP loss per share of $0.28 for the third quarter of 2026. Seeking Alpha reported that these results outperformed analyst consensus estimates of a $0.31 loss per share, representing a beat of $0.03.
Cabaletta Bio, trading under the ticker CABA, closed at $1.42 on November 4, 2026. The stock saw a session range between a low of $1.4 and a high of $1.52, as the company manages a cash position of $299.4 million reported as of September 30, 2026.